InfuSystem Holdings (INFU) Depreciation & Amortization (CF) (2010 - 2026)
InfuSystem Holdings (INFU) reported Depreciation & Amortization (CF) of $3.0 million for Q1 2026, down 0.91% on a YoY basis from $3.1 million in Q1 2025, and down 3.0% quarter-over-quarter from $3.1 million in Q4 2025.
InfuSystem Holdings (INFU) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Depreciation & Amortization (CF) for 11 years, with the latest figure at $3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 0.91% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $12.3 million (up 3.5% YoY), and the FY2025 full-year result was $12.4 million, up 7.53% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $3.0 million, down from $3.1 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $3.2 million in Q4 2024, with the low at $2.7 million in Q1 2024.
- Historically, Depreciation & Amortization (CF) has averaged $2.9 million across 5 years, with a median of $2.9 million in 2023.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) declined 26.51% — and 2025, when it advanced 15.84%.
- InfuSystem Holdings' Depreciation & Amortization (CF) stood at $2.7 million in 2022, then increased by 5.92% to $2.9 million in 2023, then rose by 9.53% to $3.2 million in 2024, then retreated by 1.1% to $3.1 million in 2025, then fell by 3.0% to $3.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $3.0 million (Q1 2026), $3.1 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.04 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 2.90 Mn |
| Dec 31, 2023 | 2.90 Mn |